Codes / ICD10CM / T65.814S

T65.814S Toxic effect of latex, undetermined, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic Effect of Latex, Undetermined, Sequela (ICD-10-CM Code: T65.814S)

Summary

This condition represents the residual effects or chronic complications following a toxic effect of latex where the intent or circumstances of the original exposure were not specified. It applies to ongoing health issues resulting from prior latex exposure, such as persistent allergic reactions or tissue damage.

Causes

The sequela arises from a previous toxic effect of latex, which may have occurred through direct skin contact, inhalation of airborne particles, or mucosal exposure. Latex is found in gloves, medical devices, and other products, and reactions can stem from sensitization or immediate contact. The original exposure details are undetermined.

Risk Factors

  • Prior history of latex exposure, especially in healthcare or manufacturing.
  • Underlying latex allergy or sensitivity.
  • Repeated exposure to latex-containing products.
  • Lack of protective measures during prior exposure.

Symptoms

  • Persistent skin reactions: chronic itching, redness, or dermatitis.
  • Respiratory issues: ongoing wheezing, coughing, or asthma-like symptoms.
  • Mucosal irritation: recurring nasal congestion, eye redness, or throat discomfort.
  • Systemic effects: fatigue or reduced tolerance to latex exposure.

Diagnosis

Diagnosis relies on clinical assessment of current symptoms and correlation with a documented history of prior latex exposure. Tests for latex-specific IgE or skin prick tests may confirm sensitivity, while imaging or physical exams evaluate residual damage.

Treatment Options

Management focuses on symptom relief and avoiding further latex exposure. This may include antihistamines, topical corticosteroids, or bronchodilators. Long-term strategies involve using latex-free alternatives and monitoring for worsening symptoms.

Prognosis and Follow-Up

Prognosis depends on the severity of residual effects and adherence to avoidance measures. Regular follow-up with healthcare providers ensures symptom control and early detection of complications. Most patients improve with consistent avoidance, though some may experience chronic issues.

Complications

  • Chronic respiratory conditions, such as persistent asthma.
  • Severe allergic reactions upon re-exposure.
  • Skin infections from chronic dermatitis.
  • Reduced quality of life due to ongoing symptoms.

Lifestyle & Prevention

  • Use latex-free products (e.g., gloves, medical devices).
  • Ensure environments (home, work) are free of latex.
  • Wear medical alert identification for latex allergy.
  • Educate others about the allergy to prevent accidental exposure.

When to Seek Professional Help

Seek care if symptoms worsen, new reactions occur, or breathing difficulties develop. Immediate medical attention is needed for signs of anaphylaxis, such as swelling, dizziness, or shortness of breath.

Tips for Medical Coders

Document the sequela nature of the condition and confirm the original toxic effect of latex. Ensure the code T65.814S is used only when the residual effects are directly linked to an undetermined prior latex exposure. Include details on the chronicity and impact on daily functioning.

Book a walkthrough

T65.814S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.